UNSPSC 51192601: Amifostine/mannitol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN700. This VA Drug Class (AN700) classifies this compound as belonging to the group PROTECTIVE AGENTS.

UNSPSC 51192601 Amifostine/mannitol, a Commodity code, covers a specialized pharmaceutical product — a cytoprotective agent used primarily in clinical oncology settings to reduce toxicity from chemotherapy and radiation therapy. State and local governments procure this drug through their health systems, correctional medical services, and public health agencies. The code reflects a narrowly defined pharmaceutical line item rather than a broader drug category, and purchasing is driven by clinical protocols at institutions with active cancer treatment or radiation oncology programs.

The source provides no recent state or local contract opportunities under this code. Activity in this Commodity is likely concentrated among large state health systems, urban county medical centers, and specialized cancer treatment facilities, though specific issuing bodies and geographic patterns cannot be characterized from the available data.